BC Cancer von Hippel Lindau (VHL) Biobank, Canada

Registration Status: Completed

Objective: The von Hippel Lindau biobank (VHLBB) is an initiative by BC Cancer to create a repository of biospecimens and data to support research with the goal of improving the care of patients with VHL disease.

Registered Biobank Name BC Cancer von Hippel Lindau (VHL) Biobank
Biobank Leader Maryam Soleimani
Country Canada
Email for biobank inquiries maryam.soleimani@bccancer.bc.ca
Principal Investigator Maryam Soleimani, Nicolette Fonseca
User Type
  • Mono: A biobank that supports a specific research project, may have few staff members, a small-scale accrual scope with little to no initial intention of releasing or distributing biospecimens to secondary parties
  • Oligo: A biobank that supports several research groups or clinical trials, may or may not be designed to release biospecimens outside their collaborative group
  • Poly: A biobank that has generally a larger accrual scope, resources, and multiple users outside the biobank proper
Biospecimen Collected: